Benjamin Graham Detailed Fundamental Analysis

Validea's guru fundamental report indicates that EDWARDS LIFESCIENCES CORP (EW) receives a 71% rating based on their Benjamin Graham-inspired Value Investor model, which favors companies with low P/B and P/E ratios, low debt, and strong earnings growth; while EW passes criteria for sales, current ratio, debt, and EPS growth, it fails the model's P/E and Price/Book ratio tests.

Analysis

Edwards Lifesciences Corp (EW) received a 71% rating from Validea's Value Investor model, inspired by Benjamin Graham's deep value principles, a score falling short of the 80% threshold that typically signals strategy interest. As a large-cap growth stock in the Medical Equipment & Supplies industry, EW exhibits fundamental strengths, passing criteria for sales, current ratio, manageable long-term debt relative to net current assets, and robust long-term EPS growth. However, the company fails the model's critical valuation tests concerning its P/E ratio and Price/Book ratio. This mixed outcome, underscored by a sentiment score of -0.1 for EW, indicates that while operational health and solvency appear sound, its current market valuation does not meet the stringent requirements of a classic deep value investment, a common characteristic for stocks categorized primarily for growth.

Key Decisions for Investors

• Investors adhering strictly to Benjamin Graham's deep value principles should note EW's failure on key valuation metrics (P/E and P/B ratios), despite its operational strengths, making it a less compelling candidate under this specific strategy.
• For growth-oriented investors, the 'fail' on value metrics might be less concerning, and the positive signals on sales, debt management, and EPS growth warrant further investigation within a growth investing framework, potentially comparing EW against growth-focused peers.
• Consider the 71% score from this value model as a specific data point; a holistic assessment should incorporate EW's valuation against industry peers and its own growth prospects rather than solely relying on deep value criteria.